DIPHTERIA,TETANUS,HEPATITIS B AND HAEMOPHILUS INFLUENZA TYPE B CONJUGATE VACCINE ADSORBED

Indications

• Poisoning
• Drug overdose
• Gastrointestinal decontamination

Dosage

Children: Refer to specific guidelines for the substance involved in poisoning or overdose, as doses vary widely based on the clinical scenario.

Adults: Refer to specific guidelines for the substance involved in poisoning or overdose, as doses vary widely based on the clinical scenario.

Mechanism of action

Adsorption occurs when molecules from a liquid or gas phase adhere to the surface of a solid, forming a film. This interaction can be influenced by various forces, including van der Waals forces, hydrogen bonding, and electrostatic interactions. In the context of activated charcoal, for example, it binds to various substances in the gut, preventing their absorption into the bloodstream and facilitating their excretion.

Pharmacodynamics

The pharmacodynamic effects of adsorbed substances depend on the specific material and its intended use. In general, adsorbents can reduce the bioavailability of certain drugs and toxins by binding them within the gastrointestinal tract and thus decreasing their systemic effects. This can be particularly advantageous in cases of poisoning or overdose, where rapid removal of the substance is desired.

Pharmacokinetics

The pharmacokinetics of adsorbed substances are complex and vary significantly depending on the specific adsorbent used. For instance, activated charcoal does not undergo metabolism and is excreted unchanged in the feces. The onset of action is rapid, as the adsorption occurs immediately upon contact in the gastrointestinal tract. The duration of effect depends on the concentration of the adsorbent and the presence of the substance to be adsorbed.

Pregnancy

Adsorbed is generally considered safe during pregnancy, but it should be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether adsorbed is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Cancer therapy
• Autoimmune diseases
• Infectious diseases
• Targeted drug delivery systems
• Vaccination strategies

Dosage

Children: Refer to specific product guidelines for dosing information, as it varies widely based on the conjugate and indication.

Adults: Refer to specific product guidelines for dosing information, as it varies widely based on the conjugate and indication.

Mechanism of action

The mechanism of action of conjugate drugs varies widely depending on the specific substances involved in the conjugation. Generally, conjugation can facilitate drug uptake into cells, enhance bioavailability, and alter the pharmacokinetics of the active drug. Some conjugates are designed to target specific receptors or tissues, thereby improving the specificity and efficacy of the therapeutic effect.

Pharmacodynamics

Pharmacodynamics of conjugate drugs is largely dependent on the nature of the conjugated entities. They may exhibit altered binding affinities, modified distribution profiles, and varying degrees of activity compared to their non-conjugated counterparts. The therapeutic effect could be amplified or diminished based on the conjugation strategy employed, with implications for potency and duration of action.

Pharmacokinetics

Pharmacokinetics of conjugate drugs is influenced by the characteristics of both the parent drug and the conjugated moiety. Factors such as absorption, distribution, metabolism, and excretion (ADME) can be significantly altered. Conjugates may exhibit improved solubility and permeability, leading to enhanced absorption and bioavailability. Metabolic pathways may also be modified, potentially altering the half-life and clearance rates of the drug.

Pregnancy

The safety of conjugate vaccines during pregnancy has not been fully established. Use during pregnancy should be based on the benefit-to-risk assessment.

Breast-feeding

Conjugate vaccines are generally considered safe during breastfeeding. Vaccination can be beneficial for the infant when the mother is immunized.

Storage

Conjugate vaccines should be stored in a refrigerator at 2-8 degrees Celsius and protected from light. Do not freeze.

Indications

• Diphtheria infection
• Respiratory diphtheria
• Cutaneous diphtheria
• Prevention of diphtheria in exposed individuals

Dosage

Adults: Consult local guidelines or the BNF for appropriate dosing for diphtheria treatment.

Mechanism of action

Corynebacterium diphtheriae produces a potent exotoxin that inhibits protein synthesis in host cells by inactivating elongation factor-2 (EF-2) through ADP-ribosylation. This leads to cell death and contributes to the local tissue damage and systemic effects observed in diphtheria. The diphtheria toxoid vaccine stimulates the immune system to produce antibodies against the toxin, thereby preventing the disease.

Pharmacodynamics

The clinical effects of diphtheria are primarily due to the diphtheria toxin, which causes local inflammation and tissue necrosis in the throat, leading to the characteristic pseudomembrane formation. Systemically, the toxin can lead to myocarditis, peripheral neuropathy, and other complications. Antibiotics help to control the infection and reduce toxin production, while antitoxin neutralizes the circulating toxin.

Pharmacokinetics

The pharmacokinetics of diphtheria antitoxin and antibiotics varies. Diphtheria antitoxin is administered intravenously or intramuscularly, with effects seen rapidly as it neutralizes circulating toxin. Antibiotics like penicillin and erythromycin are absorbed from the gastrointestinal tract and distributed throughout the body, with renal excretion as the primary route of elimination. The half-lives of these antibiotics typically range from 1 to 3 hours, necessitating multiple doses for effective treatment.

Contra-indications

• Severe allergic reaction to diphtheria toxoid or any component of the vaccine

Adverse effects

• Local reaction at the injection site
• Fever
• Fatigue
• Malaise
• Headache
• Nausea
• Irritability
• Anaphylaxis (rare)

Interactions

• Live attenuated vaccines should not be administered simultaneously with diphtheria vaccine; separate by at least 4 weeks
• Immunosuppressive therapies may reduce the effectiveness of the vaccine

Precautions

• History of moderate or severe acute illness
• History of allergic reactions to vaccines
• Caution in individuals with a history of Guillain-Barré syndrome

Pregnancy

Diphtheria vaccine is recommended during pregnancy if there is a risk of exposure to the disease, as it provides passive immunity to the newborn.

Breast-feeding

The vaccine is considered safe during breastfeeding.

Storage

Store in a refrigerator at 2°C to 8°C. Do not freeze.

Formulations

• Diphtheria toxoid vaccine

Indications

• Bacterial meningitis
• Pneumonia
• Epiglottitis
• Otitis media
• Sinusitis
• Bronchitis

Dosage

Children: Refer to specific antibiotic guidelines for pediatric dosing based on the type and severity of the infection caused by Haemophilus species.

Adults: Refer to specific antibiotic guidelines for dosing based on the type and severity of the infection caused by Haemophilus species.

Mechanism of action

H. influenzae adheres to epithelial cells via pili and other surface structures, allowing colonization of the nasopharynx. The encapsulated strains evade phagocytosis due to their polysaccharide capsule, which inhibits opsonization and complement activation. This leads to the systemic spread of the bacteria and can result in severe infections if not effectively treated.

Pharmacodynamics

H. influenzae can produce various virulence factors, including polysaccharide capsules, endotoxins, and enzymes that contribute to its pathogenicity. The bacteria can resist the effects of certain antibiotics through mechanisms such as beta-lactamase production, which hydrolyzes beta-lactam antibiotics, rendering them ineffective. The host's immune response is often inadequate to clear the infection due to the bacterium's ability to evade immune detection.

Pharmacokinetics

The pharmacokinetics of antibiotics used to treat H. influenzae infections vary based on the specific drug. Common antibiotics include ampicillin and ceftriaxone. The absorption, distribution, metabolism, and excretion depend on the antibiotic used. For example, ampicillin is well absorbed from the gastrointestinal tract, widely distributed in body tissues and fluids, and eliminated primarily via renal excretion.

Adverse effects

• Injection site reactions
• Fever
• Rash
• Irritability
• Anaphylaxis (rare)

Precautions

• Caution in patients with a history of severe allergic reactions
• Monitor for signs of anaphylaxis after administration
• Assess for underlying immunocompromised conditions

Pregnancy

Safety during pregnancy has not been established; use only if clearly needed.

Breast-feeding

Generally considered safe, but consult a healthcare provider.

Storage

Store at 2-8 degrees Celsius. Do not freeze. Protect from light.

Formulations

• Injectable suspension
• Oral tablets

Indications

• Acute viral hepatitis
• Chronic hepatitis B
• Chronic hepatitis C
• Autoimmune hepatitis
• Alcoholic hepatitis
• Non-alcoholic fatty liver disease

Dosage

Children: Paediatric dosing also varies significantly based on the specific condition and medication. As with adult dosing, it is important to refer to the BNF for Children for specific recommendations.

Adults: Dosing for adult patients varies widely depending on the specific antiviral agent used and the type of hepatitis. It is essential to refer to specific guidelines or the BNF for precise dosing.

Mechanism of action

In viral hepatitis, the viruses typically enter liver cells and replicate, leading to cellular injury and inflammation. The immune response to the infection contributes to liver damage. Antiviral therapies aim to inhibit viral replication, either by directly targeting viral enzymes or by modulating the host immune response.

Pharmacodynamics

The pharmacodynamics of antiviral agents used in hepatitis treatment involve the inhibition of viral replication, reduction of viral load, and improvement of liver function. This can lead to a decrease in serum liver enzymes (ALT and AST) and an improvement in clinical symptoms. In chronic hepatitis B and C, sustained virologic response is the goal, indicating effective viral suppression.

Pharmacokinetics

The pharmacokinetics of antiviral medications used for hepatitis can vary significantly depending on the specific drug. Generally, these agents are absorbed from the gastrointestinal tract, metabolized in the liver, and excreted through urine or feces. The half-lives of these drugs can vary, influencing dosing schedules.

Pregnancy

Consult medical guidelines as hepatitis can pose risks during pregnancy; specific management depends on the type of hepatitis.

Breast-feeding

Consult healthcare providers, as the safety of certain hepatitis medications during breastfeeding varies.

Storage

Store in a cool, dry place away from direct sunlight; specific storage conditions may vary based on the medication used.

Indications

• Prevention of influenza virus infection
• Reduction of the severity of influenza illness
• Protection for high-risk groups against influenza complications

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations for paediatric patients based on age and health status.

Adults: Refer to the BNF for specific dosing recommendations for adult patients based on the type of vaccine and individual health status.

Mechanism of action

Influenza vaccines stimulate the immune system to produce antibodies against the influenza virus. When the body is exposed to the virus, these antibodies help to prevent infection or mitigate the severity of the disease. The vaccines may contain inactivated virus or live attenuated virus, depending on the formulation.

Pharmacodynamics

Upon administration of the influenza vaccine, the immune system recognizes the viral antigens and generates a specific immune response. This response includes the production of antibodies, primarily immunoglobulin G (IgG), which can neutralize the virus and prevent its replication. The response varies based on individual health status and age.

Pharmacokinetics

The pharmacokinetics of influenza vaccines vary by type. After intramuscular or subcutaneous administration, the vaccine components are absorbed into the systemic circulation, leading to the production of antibodies. Peak antibody levels typically occur within 2 to 4 weeks after vaccination. The half-life of antibodies can vary, but they generally persist for several months, providing immunity against future infections.

Interactions

• normal immunoglobulin + influenza vaccine live: Unknown (decreases efficacy)

Pregnancy

Influenza vaccination is recommended during pregnancy, especially in the second and third trimesters, as it protects both mother and fetus.

Breast-feeding

Influenza vaccination is safe during breastfeeding and provides passive immunity to the infant.

Storage

Influenza vaccines should be stored in a refrigerator at 2 to 8 degrees Celsius. Do not freeze.

Indications

• Tetanus prophylaxis
• Treatment of tetanus infection
• Management of tetanus symptoms

Dosage

Children: Refer to the specific guidelines for tetanus immunoglobulin and other supportive treatments as per clinical protocols.

Adults: Refer to the specific guidelines for tetanus immunoglobulin and other supportive treatments as per clinical protocols.

Mechanism of action

The tetanus toxin binds to the presynaptic membrane of motor neurons and is transported retrogradely to the spinal cord, where it interferes with neurotransmitter release, particularly inhibiting the release of glycine and gamma-aminobutyric acid (GABA), leading to unopposed motor neuron activity and resultant muscle rigidity and spasms.

Pharmacodynamics

Tetanus toxin is one of the most potent toxins known, with effects that can manifest within hours of exposure. The toxin's ability to block inhibitory neurotransmitter release results in a state of continuous muscle contraction, known as tetany. The clinical presentation of tetanus includes trismus (lockjaw), muscle rigidity, and autonomic instability, among others.

Pharmacokinetics

The pharmacokinetics of tetanus toxin are complex due to its high potency and the nature of its action. Following entry into the body, the toxin binds to nerve endings and is internalized, leading to its effects on neurotransmitter release. The half-life of the toxin is not well defined as it does not circulate freely in the bloodstream but acts locally at the neuromuscular junction. Recovery from the effects of the toxin may take weeks to months, depending on the severity of the infection and the treatment provided.

Adverse effects

• Pain at the injection site
• Fever
• Fatigue
• Headache
• Nausea

Precautions

• Ensure patient is up to date with vaccinations
• Monitor for allergic reactions post-vaccination
• Consider history of neurological disorders

Pregnancy

Tetanus vaccination is considered safe during pregnancy and is recommended to protect both the mother and the newborn.

Breast-feeding

Tetanus vaccination is safe during breastfeeding and does not affect the nursing infant.

Storage

Store in a refrigerator at 2–8 degrees Celsius. Do not freeze.

Formulations

• Tetanus toxoid vaccine

Indications

• Prevention of infectious diseases such as measles, mumps, rubella, hepatitis B, influenza, and human papillomavirus (HPV)
• Travel vaccinations for diseases endemic to certain regions
• Vaccination for at-risk populations, such as those with compromised immune systems or specific occupational exposures

Dosage

Children: Dosage varies by vaccine type and age; refer to the BNF for Children for specific dosing information.

Adults: Dosage varies by vaccine type and indication; refer to specific guidelines for each vaccine.

Mechanism of action

Vaccines work by mimicking an infection. They introduce a harmless component of a pathogen (antigen) to the immune system, prompting the body to produce an immune response. This includes the generation of antibodies and memory cells that provide long-term immunity. Upon subsequent exposure to the actual pathogen, the immune system is primed to respond more rapidly and effectively.

Pharmacodynamics

The pharmacodynamics of vaccines involves the activation of both humoral and cellular immunity. Vaccines stimulate B cells to produce antibodies against the pathogen, while T cells are activated to destroy infected cells. This dual response helps to establish immunological memory, which enables a faster and more robust response upon re-exposure to the pathogen.

Pharmacokinetics

Vaccines are administered via various routes, including intramuscular, subcutaneous, and oral. After administration, the antigens are presented to antigen-presenting cells, which activate T cells and stimulate B cell proliferation and differentiation. The half-life of vaccine-induced immunity varies depending on the type of vaccine, with some providing lifelong immunity and others requiring booster doses to maintain protection.

Contra-indications

• Severe allergic reaction (anaphylaxis) to a component of the vaccine
• Severe immunocompromised state for live attenuated vaccines

Adverse effects

• Local reactions at the injection site (pain, redness, swelling)
• Fever
• Fatigue
• Headache
• Muscle pain
• Joint pain
• Nausea

Interactions

• Immunosuppressive medications may reduce vaccine efficacy
• Concurrent administration of some vaccines may require spacing to optimize immune response

Precautions

• History of allergic reactions to vaccines or vaccine components
• Pregnancy (specific vaccines may be contraindicated)
• Moderate to severe acute illness with or without fever

Pregnancy

Consult healthcare provider. Some vaccines are contraindicated during pregnancy, while others are recommended.

Breast-feeding

Generally considered safe, but consult healthcare provider regarding specific vaccines.

Storage

Store in a refrigerator at 2-8°C. Do not freeze. Protect from light.

Formulations

• Liquid suspension for injection
• Lyophilized powder for reconstitution